Literature DB >> 17966108

Promise and pitfalls of administrative data in evaluating pregnancy outcomes.

Elizabeth B Andrews1, Patricia Tennis.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17966108     DOI： 10.1002/pds.1499

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  8 in total

Review 1.  Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Eur J Clin Pharmacol       Date:  2011-11-13       Impact factor: 2.953

2.  Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal.

Authors:  Stephanie Dellicour; Philippe Brasseur; Per Thorn; Oumar Gaye; Piero Olliaro; Malik Badiane; Andy Stergachis; Feiko O ter Kuile
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

3.  Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs.

Authors:  Pierre-Olivier Blotière; Fanny Raguideau; Alain Weill; Elisabeth Elefant; Isabelle Perthus; Véronique Goulet; Florence Rouget; Mahmoud Zureik; Joël Coste; Rosemary Dray-Spira
Journal:  Neurology       Date:  2019-06-12       Impact factor: 9.910

4.  Algorithms to estimate the beginning of pregnancy in administrative databases.

Authors:  Andrea V Margulis; Soko Setoguchi; Murray A Mittleman; Robert J Glynn; Colin R Dormuth; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-05-02       Impact factor: 2.890

Review 5.  The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.

Authors:  Casey R Tak; Kathleen M Job; Katie Schoen-Gentry; Sarah C Campbell; Patrick Carroll; Maged Costantine; Diana Brixner; Angela K Birnbaum; Catherine M T Sherwin
Journal:  Eur J Clin Pharmacol       Date:  2017-06-09       Impact factor: 2.953

Review 6.  [Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].

Authors:  N Bergemann; W E Paulus
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

7.  Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014).

Authors:  Julie M Petersen; Daina B Esposito; Martha M Werler
Journal:  Arch Womens Ment Health       Date:  2020-03-28       Impact factor: 3.633

8.  Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.

Authors:  Akeem Yusuf; Victoria Chia; Fei Xue; Daniel D Mikol; Lisa Bollinger; Charles Cangialose
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-09-21       Impact factor: 2.890
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.